Ask AI

ASH Conference Orlando 2025

 
Virtual Simulcast
 
In-Person
 
Free CME/CE Credits

Orlando Annual Hematology 2025

Review the latest breakthroughs in cancer treatments coming out of Orlando and earn free CME/CE credits! Access to presentation slidesets, clinical resources, on-demand webcasts, and expert commentaries on CLL, FL, and MCL.

Don't miss out on this opportunity to learn from experts' knowledge and experience for the improvement of patient care.

The best part? You don't need to be registered to attend the Orlando conference to attend the symposia! Choose any or all options, below.

 

Dates Friday, December 5, 2025

 

Time Varies per Event
Timezone Converter ›

 

Location The Hyatt Regency Orlando
9801 International Dr.
Orlando, FL 32819

Event Schedule

Attend in-person or via virtual simulcast.

December

05

2025

December

05

2025

11:00 AM - 1:30 PM Eastern Time (ET)

In-person

11:30 AM - 1:30 PM Eastern Time (ET)

Virtual

December

05

2025

Featured Faculty

Faculty

Jeremy S. Abramson, MD, MMSc

  • Director, Center for Lymphoma
  • Massachusetts General Hospital
  • Professor of Medicine
  • Harvard Medical School
  • Boston, Massachusetts
Faculty

Stephen Ansell, MD, PhD

  • Associate Professor of Medicine
  • Department of Hematology
  • Mayo Clinical Cancer Center
  • Rochester, Minnesota
Faculty

Jesús G. Berdeja, MD

  • Director of Multiple Myeloma Research
  • Sarah Cannon Research Institute
  • Sarah Cannon Center for Blood Cancer
  • Tennessee Oncology
  • Nashville, Tennessee
Faculty

Matthew Cortese, MD, MPH

  • Staff Physician and Assistant Professor of Oncology
  • Division of Hematology/Oncology
  • Department of Medicine
  • Lymphoma Section and Department of Cancer Genetics & Genomics
  • Roswell Park Comprehensive Cancer Center
  • Buffalo, New York
Faculty

Stacy E. Croteau, MD, MMS

  • Director, Hemophilia/VWD Program
  • Boston Children’s Hospital
  • Medical Director
  • Boston Bleeding Disorders Center
  • Assistant Professor of Pediatrics
  • Harvard Medical School
  • Boston, Massachusetts
Faculty

Brian Hill, MD, PhD

  • Director of the Lymphoid Malignancies Program
  • Associate Professor, Cleveland Clinic Lerner College of Medicine
  • Staff Physician
  • Department of Hematology & Medical Oncology
  • Cleveland Clinic Taussig Cancer Institute
  • Cleveland, Ohio
Faculty

Carol Ann Huff, MD

  • Professor of Oncology and Medicine
  • Multiple Myeloma Program
  • Johns Hopkins University
  • Medical Director
  • Sidney Kimmel Comprehensive Cancer Center
  • Baltimore, Maryland
Faculty

Amrita Krishnan, MD, FACP

  • Director, Judy and Bernard Briskin Center for Myeloma
  • Executive Director Hematology
  • City of Hope Orange County
  • Nason Hollingsworth Family Chair in Myeloma
  • Irvine, California
Faculty

David Maloney, MD, PhD

  • Associate Member, Clinical Research Division
  • Fred Hutchinson Cancer Research Center
  • Associate Professor of Medicine
  • Division of Oncology
  • University of Washington School of Medicine
  • Seattle, Washington
Faculty

Thomas G. Martin, MD

  • Clinical Professor of Medicine
  • Associate Chief, Division of Hematology/Oncology
  • Director, Hematology, Blood and Marrow Transplantation and Cell Therapy
  • Helen Diller Family Comprehensive Cancer Center
  • UCSF Medical Center
  • San Francisco, California
Faculty

Peter Martin, MD

  • Professor of Medicine, NYU Grossman School of Medicine
  • Perlmutter Cancer Center
  • New York, New York
Faculty

Toby Maher, MD, PhD, FRCP

  • Professor of Medicine
  • Division of Pulmonary, Critical Care, and Sleep Medicine
  • University of Southern California
  • Director of Interstitial Lung Disease
  • Division of Pulmonary, Critical Care, and Sleep Medicine
  • Keck Medicine of USC
  • Los Angeles, California
Faculty

Sameer A. Parikh, MBBS

  • Consultant, Division of Hematology
  • Chair, CLL Disease Team
  • Vice Chair, Lymphoid Malignancies Disease Group
  • Mayo Clinic Comprehensive Cancer Center
  • Associate Professor of Medicine and Assistant Professor of Oncology
  • Mayo Clinic Alix School of Medicine and Science
  • Rochester, Minnesota
Faculty

Steven Pipe, MD

  • Professor of Pediatrics and Pathology
  • Laurence A. Boxer Research Professor of Pediatrics
  • University of Michigan
  • Ann Arbor, Michigan
Faculty

Jerald Radich, MD

  • Translational Science & Therapeutics Division
  • Kurt Enslein Endowed Chair
  • Fred Hutchinson Cancer Center
  • Seattle, Washington
Faculty

Adriana Rossi, MD

  • Assistant Professor of Medicine
  • Director of Myeloma CART and Stem Cell Transplant Clinical Program
  • Center of Excellence for Multiple Myeloma
  • Tisch Cancer Institute
  • Icahn School of Medicine
  • Mount Sinai Hospital
  • New York, New York
Faculty

Gilles Salles, MD, PhD

  • Service Chief, Lymphoma Service
  • Steven Greenberg Chair
  • Memorial Sloan Kettering Cancer Center
  • Professor of Medicine
  • Weill Cornell Medical College
  • New York, New York
Faculty

Laurie H. Sehn, MD, MPH

  • Chair, Lymphoma Tumor Group
  • BC Cancer
  • Clinical Professor
  • University of British Columbia
  • Vancouver, Canada
Faculty

Neil P. Shah, MD, PhD

  • Edward S. Ageno Distinguished Professor in Hematology/Oncology
  • Director, UCSF Molecular Medicine Residency Program
  • University of California, San Francisco
  • San Francisco, California
Faculty

Mitchell R. Smith, MD, PhD

  • Chief Medical Officer
  • The Follicular Lymphoma Foundation
  • London, United Kingdom
Faculty

B. Douglas Smith, MD

  • Professor, Oncology
  • Division of Hematologic Malignancies
  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
  • Baltimore, Maryland
Faculty

Niels Van de Donk, MD, PhD

  • Professor of Hematology
  • Department of Hematology
  • Amsterdam UMC, Location VUmc
  • Amsterdam, Netherlands

Accreditation

Aligning Discovery With Clinical Practice: Applying Expert Consensus Guidelines to Improve Patient Outcomes in CLL/SLL
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
Registered Nurses: 2.00 Nursing contact hour
Physician Assistants: maximum of 2.00 hours of AAPA Category 1 CME credits
Pharmacists: 2.00 contact hours (0.2 CEUs)
ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
Registered Nurses: 2.00 Nursing contact hour
Physician Assistants: maximum of 2.00 hours of AAPA Category 1 CME credits
Pharmacists: 2.00 contact hours (0.2 CEUs)
ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Beyond Chemotherapy: Patient Voices and Expert Insights on Using Precision Therapies to Enhance Personalized Care of Follicular Lymphoma
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Advancing Hemophilia Care—Uniting Expert Insights and Community Voices to Shape the Future of Non-Factor Replacement Therapy
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Advancing Outcomes in Lymphoma Care: A Master Class on Integrating the CAR T-Cell Therapies into Clinical Practice
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

A Master Class in CP-CML: New Agents, Treatment Goals, and Clinical Challenges
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

Myeloma Myth Busters: Investigating the Now, Soon, and Future Clinical Implications of CELMoDs
Physicians: maximum of 2.00 AMA PRA Category 1 Credits
Physicians ABIM MOC: maximum of 2.00 Medical Knowledge MOC points

The Hyatt Regency Orlando

9801 International Dr.
Orlando, FL 32819

Friday Satellite Symposium preceding the 67th ASH Annual Meeting and Exposition.

Aligning Discovery With Clinical Practice: Applying Expert Consensus Guidelines to Improve Patient Outcomes in CLL/SLL
Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC.
Supported by educational grants from AstraZeneca and Lilly.

Steady Progress in Multiple Myeloma: Applying New Data and Updated Guidelines Throughout Treatment
Provided by the National Comprehensive Cancer Network (NCCN) in collaboration with Clinical Care Options, LLC.
Supported by independent medical education grants from AbbVie and GSK.
Supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
Supported by a medical education grant from Karyopharm Therapeutics.

Beyond Chemotherapy: Patient Voices and Expert Insights on Using Precision Therapies to Enhance Personalized Care of Follicular Lymphoma
Provided by Clinical Care Options, LLC in partnership with the Follicular Lymphoma Foundation
Supported by educational grants from AstraZeneca, Genentech, a member of the Roche Group, Incyte Corporation, Novartis Pharmaceuticals Corporation, and Regeneron Pharmaceuticals, Inc.

Advancing Hemophilia Care—Uniting Expert Insights and Community Voices to Shape the Future of Non-Factor Replacement Therapy
Provided by Clinical Care Options, LLC
Supported by an educational grant from Novo Nordisk.

Advancing Outcomes in Lymphoma Care: A Master Class on Integrating the CAR T-Cell Therapies into Clinical Practice
Provided by Clinical Care Options, LLC
Supported by an educational grant from Bristol Myers Squibb.

A Master Class in CP-CML: New Agents, Treatment Goals, and Clinical Challenges
Provided by Clinical Care Options, LLC
Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Myeloma Myth Busters: Investigating the Now, Soon, and Future Clinical Implications of CELMoDs
Provided by Clinical Care Options, LLC
Supported by an educational grant from Bristol Myers Squibb.